ABSTRACT Tyrosine aminotransferase (TyrATase; L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) from rat liver is subject to glucocorticoid and cAMP as well as developmental control. To isolate DNA sequences encoding TyrATase, we constructed a cDNA library from rat liver poly(A)+RNA enriched for TyrATase mRNA. Recombinant plasmids were screened by differential colony hybridization to poly(A)+RNA isolated from adrenalectomized and dexamethasone-treated animals. Differentially hybridizing plasmids were then shown to contain TyrATase cDNA sequences by their ability to select a mRNA whose in vitro translation product is immunoprecipitable with antiserum against TyrATase. In confirmation, we detect mRNA homologous to TyrATase cDNA sequences in hepatoma cell lines known to contain TyrATase activity but not in a cell line lacking this activity. We show that treatment of rats with dexamethasone or N6,02'-dibutyryladenosine 3',5'-cyclic monophosphate leads to a 5-to 10-fold increase in the amount of TyrATase mRNA.
Tyrosine aminotransferase (TyrATase; L-tyrosine:2-oxoglutarate aminotransferase; EC 2.6.1.5), a liver enzyme involved in gluconeogenesis, is subject to complex control. Its basal activity rises rapidly after treatment with glucocorticoids (1) or with glucagon or N6,02'-dibutyryladenosine 3',5'-cyclic monophosphate (Bt2cAMP) (2, 3) , in parallel with an increase in the level of TyrATase mRNA (4, 5) . In some hepatoma cell lines, the enzyme is expressed and similarly regulated as in liver cells (6, 7) . Due to the work of Tomkins et al. (8) , the glucocorticoid induction of TyrATase in hepatoma cells has become a model system for effector-mediated control of gene expression in mammalian cells.
In addition to the hormonal induction, TyrATase is also regulated developmentally. Enzyme activity, virtually absent in fetal rat liver, starts to increase 2 hr after birth, reaches a maximum by 12 hr, and decreases to the adult level by day 2 (9) . Premature induction of TyrATase activity can be elicited in fetal rats by in utero injection of Bt2cAMP but not by hydrocortisone (10) . In contrast, both compounds induce TyrATase activity prematurely in fetal rat liver explants (11) .
A control region located on chromosome 7 in mice is required for the expression and inducibility of TyrATase, as suggested by genetic and biochemical analysis of albino mutants (12) . In these mutants, characterized by overlapping deletions around the albino locus, the activity ofvarious liver enzymes, including TyrATase, is affected. Although the basal level of TyrATase is severely reduced in these mutants and the enzyme is no longer inducible by glucocorticoids, the structural gene for TyrATase is still present (13) , suggesting the loss ofone or more regulatory genes.
Since a molecular description ofthese complex control mechanisms depends on specific DNA probes, we have isolated recombinant plasmids containing TyrATase cDNA sequences.
With the use of one of these TyrATase cDNA clones as probe, we show that TyrATase mRNA sequences increase after treatment of rats with dexamethasone and Bt2cAMP.
MATERIALS AND METHODS
Isolation and Translation of RNA. Male Wistar rats (150-200 g) were injected with dexamethasone (10 ,ug/100 g of body weight) 4 hr before sacrifice. Bt2cAMP (5 mg/100 g of body weight) was administered 1 hr before death. Adrenalectomized rats served as controls. Hepatoma cell lines Fao, C2, and H5 (7, 14) were grown in Dulbecco's modified Eagle's minimal essential medium/5% fetal calf serum/5% calf serum (Seromed, Munich, Federal Republic of Germany) and treated with 1 uM dexamethasone for 24 hr before harvest. Total poly(A)+RNA was isolated from cells or livers by LiCl/urea extraction as described (15) .
For cloning or screening purposes, 200-500 ,ug of poly-(A)+RNA was size fractionated on a 1.2% low-melting-agarose gel containing 8 mM methylmercury hydroxide (16) . RNA was recovered from melted gel slices by extraction with a quarternary ammonium detergent as described by Langridge et al. (17) . RNA from the individual fractions was assayed for TyrATase mRNA by in vitro translation in a reticulocyte lysate system (New England Nuclear). The resulting polypeptides were immunoprecipitated by TyrATase antibodies prepared by Rowekamp et aL (18) . These antibodies neutralize TyrATase activity and show only one precipitation line in an Ouchterlony test and after countercurrent electrophoresis. Antigen-antibody complexes were isolated by adsorption on Staphylococcus aureus cells (Pansorbin; Calbiochem) and subjected to gel electrophoresis according to Laemmli (19) . Protein bands were detected by fluorography (20) .
Construction and Differential Screening of Recombinant Plasmids. Enriched mRNA was transcribed into double-stranded cDNA with avian myeloblastosis virus reverse transcriptase (a gift of W. Beard) according to Wickens et al (21) , with oligo(dT) as primer. The double-stranded cDNA was treated with nuclease S1, tailed with dCTP, hybridized to Pst I-digested poly(G)-tailed pBR322, and used to transform Escherichia coli 5K (22) according to Dagert and Ehrlich (23) . Colony hybridization was carried out as described by Grunstein and Hogness (24) with the modification given by Grosveld et aL (25) . Filters were probed with size-fractionated (see above) 32P-labeled RNA derived from adrenalectomized and dexamethasone-treated animals. The specific activity of the [32P]RNA was 2 to 3 X 107 cpm/,ug of RNA; the hybridization mixture contained 3-6 X 105 cpm/ml. Hybridization and in vitro labeling of RNA were carried out as described (26) .
All cloning experiments were performed in compliance with the German guidelines on recombinant DNA research.
Abbreviations: TyrATase, tyrosine aminotransferase; Bt2cAMP, N6,02'-dibutyryladenosine 3',5'-cyclic monophosphate. 7205 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement' in accordance with 18 U. S. C. §1734 solely to indicate this fact. ameter, 13 mm; BA 85 Schleicher & Schuell) and further processed as described by Ricciardi et aL (27) . After extensive prehybridization treatment and washing, hybridization (five filters together) was carried out for 36 hr at 37TC in 2 ml of55% formamide/0.6 M NaCl/25 mM Pipes, pH 6.7/1 mM EDTA/0. 1% NaDodSO4 containing 800 jig of poly(A)+RNA from dexamethasone-stimulated rats. After washing, the RNA was eluted individually from the filters in three 200-,ul portions of H20, precipitated with ethanol after addition of 10 ,ug ofpoly(C), and assayed by in vitro translation followed by immunoprecipitation * (see above). Electrophoresis and Blot Hybridizationof RNA. Poly(A)+RNA (10 pug per lane) was separated on 0.8% agarose/formaldehyde gels and transferred to nitrocellulose filters as described by Dobner et al. (28) . The blots were hybridized to nick-translated
[32P]DNA (specific activity, 1 to 2 x 107 cpm/ptg of DNA), washed, dried, and subjected to autoradiography.
FIG. 1. Differential colony hybridization of cDNA clones with in vitro-32P-labeled rat liver poly(A)+RNA isolated from adrenalectomized (A) and dexamethasone-treated (B) animals. Recombinant clones were transferred in groups of 48 to two sets of nitrocellulose filters by using a replica plating device. The filters were prepared for colony hybridization as described (24, 25 select mRNAs from poly(A)+RNA isolated from the livers of dexamethasone-treated rats. The hybridized mRNAs were released and translated in vitro, and the translation products were analyzed before and after immunoprecipitation by NaDodSO4/polyacrylamide gel electrophoresis. Lanes: 1, translation products from 1 ,jg of total rat liver poly(A)+RNA immunoprecipitated with antibodies directed against TyrATase (TAT) and against tryptophan oxygenase (TO); 2, 4, 6, and 8, proteins synthesized by mRNA selected by clones pcTAT-1, -2, -3, and -4, respectively; 3, 5, 7, and 9, anti-TyrATase immunoprecipitates of translation products shown in lanes 2, 4, 6, and 8, respectively. Approximately three-fifths of the total translation products shown in lanes 2, 4, 6, and 8 were used for the immunoprecipitates. The thick protein bands below the TyrATase bands in these lanes are endogenous to the reticulocyte translation system used. dGdC-tailing technique and cloned in E. coli 5K. A total of 1,500 recombinant plasmids was obtained.
To identify clones containing sequences of hormonally inducible RNAs, we grew the recombinant library in groups of 48 colonies on duplicate nitrocellulose filters and hybridized one set of filters with 32P-labeled rat liver poly(A)'RNA from adrenalectomized rats and the other set with labeled RNA from dexamethasone-treated rats. The RNAs used for hybridization were enriched for TyrATase mRNA about 20-fold by size fractionation. An example of a differential signal obtained in this screen is shown in Fig. 1 . In total, we detected 41 differentially hybridizing colonies. However, only five of these proved to be truly differential on retesting (not shown).
The plasmid DNAs corresponding to these five clones were individually purified, bound to nitrocellulose filters, and hybridized with poly(A)+RNA from dexamethasone-treated animals. The RNAs hybridizing to the plasmid DNAs were eluted from the filters and translated in vitro. Analysis of the translation products by gel electrophoresis showed that four of the five plasmids selected a mRNA encoding a polypeptide with a molecular weight of 53,000, the size of TyrATase (29) (Fig. 2,  lanes 2, 4, 6 , and 8). This polypeptide was positively identified as TyrATase in all four cases by immunoprecipitation with antibody directed against TyrATase (Fig. 2, lanes 3, 5, 7 , and 9). The fifth plasmid reproducibly gave rise to several polypeptides in the hybrid-selected translation assay, none of which react with the TyrATase antibody; this clone hybridizes to several distinct poly(A)+RNA species in reverse Southern blot experiments (data not shown).
The monospecificity of the TyrATase antiserum used has been demonstrated previously by the fact that only one precipitation line is formed in an Ouchterlony test as well as after countercurrent electrophoresis (18) . In addition, when a tryptophan oxygenase cDNA clone (30) was used for hybrid selection, the translation product directed by the selected mRNA was precipitated by tryptophan oxygenase antibodies but not by our TyrATase antiserum (not shown).
The four clones characterized by the immunoprecipitation shown in Fig. 2 were considered to be TyrATase specific and were designated pcTAT-1, -2, -3, and 4. The sizes ofthe inserts in clones pcTAT-1-4 are, respectively, 520, 560, 600, and 830 base pairs. Three of them cross-hybridize with each other (pcTAT-1, -3, and -4), while pcTAT-2 does not cross-hybridize and therefore must be derived from another region of the TyrATase mRNA. This interpretation has been confirmed by the observation'that pcTAT-2 and pcTAT-3 DNAs hybridize to different restriction fragments of TyrATase genomic clones (unpublished data).
Hormonally Induced Changes in the Relative Amounts of TyrATase mRNA in Rat Liver. Previous more indirect studies of the induction of TyrATase by glucocorticoids and by Bt2cAMP have shown that the increase in specific protein synthesis is accompanied by an increase in the concentration of translatable TyrATase mRNA (4, 5) . The availability of a DNA probe now permits direct measurement of the level of TyrATase mRNA sequences under a variety ofhormonal conditions. Poly(A)+RNA was isolated from rat liver 4 hr after administration of dexamethasone or 1 hr after administration of Bt2cAMP, when maximal induction of TyrATase activity occurs (4, 5) . As a control, we used poly(A)+RNA from livers ofadrenalectomized rats. Each RNA was examined by reverse Southern blotting.(28) using 32P-labeled pcTAT-3 DNA as hybridization probe. Since the concentration of albumin mRNA does not *change on induction (31, the filters were also probed with a2 labeled albumin cDNA sequence as a control for variable contents of rRNA in the different poly(A)+RNA preparations. As shown in Fig. 3A (4) . A similar result is obtained with Bt2cAMP (Fig. 3A, lane 5) . Ifwe again correct for.albumin mRNA (lanes 1 and 2) , we observe an induction factor of about 10 compared with the control animal (lane 4), again in good agreement with previous more-indirect measurements (5) .
A detailed analysis of the time course of accumulation of TyrATase mRNA and of changes in the rate of transcription of the TyrATase gene in response to the various effectors will make possible a comparison with the recent similar analysis of glucocorticoid control ofthe tryptophan oxygenase gene in rat liver (unpublished data).
An analysis of TyrATase mRNA in some hepatoma cell lines, all of which are descendants of Reuber hepatoma, is shown in Fig. 3B . A detailed history ofthese celL-ines, which encompass well-differentiated, liver cell-like, and dedifferentiated cell lines, is given by Deschatrette-and Weiss (7) and Deschatrette et aL (14) . Fao cells, which express most liver functions, and C2, which are dedifferentiated but still synthesize TyrATase, show a RNA of the expected size after hybridization with the TyrATase probe (Fig. 3B, lanes 1 and 3) . In contrast, H5 cells, which have no detectable TyrATase activity (14) , do not contain hybridizable TyrATase mRNA (Fig. 3B, lane 2) . Whether the TyrATase gene in these cells is silent or lost has yet to be shown.
It should be noted that the estimated size ofabout 2,400 bases of the TyrATase mRNA, measured on reverse Southern blots relative to albumin mRNA and rRNAs (not shown), agrees well with earlier estimates (32) .
The isolation of TyrATase cDNA clones now allows detailed analysis of the mechanism of the complex developmental and hormonal regulation of the synthesis of this enzyme and a description of the chromosomal gene. Comparison with the regulation of the rat tryptophan oxygenase gene,. which we have recently isolated (30) , should allow a deeper understanding of how different members of the glucocorticoid domain (33) are regulated. The availability of TyrATase clones will also allow a molecular attack on the regulatory gene (or genes) located on chromosome 7 that is involved in control of the expression of TyrATase and other liver enzymes (12, 13) .
